1. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT.
- Author
-
Alberts, Ian, Sachpekidis, Christos, Prenosil, George, Viscione, Marco, Bohn, Karl, Mingels, Clemens, Shi, Kuangyu, Ashar-Oromieh, Ali, and Rominger, Axel
- Subjects
Digital PET ,List mode acquisition ,PET/CT ,Positron emission tomography ,Body Weight ,Fluorodeoxyglucose F18 ,Humans ,Image Processing ,Computer-Assisted ,Neoplasms ,Positron Emission Tomography Computed Tomography ,Radiopharmaceuticals ,Retrospective Studies ,Sensitivity and Specificity ,Signal-To-Noise Ratio - Abstract
PURPOSE: To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. METHODS: Twenty-one randomly selected patients who underwent oncological [18F]-FDG PET/CT on a digital PET/CT were retrospectively evaluated. Scan data were anonymously obtained and reconstructed in list-mode acquisition for a standard 2 min/bed position (bp), 1 min/bp and 30 s/bp (100%, 50% and 25% time or applied activity, respectively). Scans were randomized and read by two nuclear medicine physicians in a consensus read. Readers were blind to clinical details. Scans were evaluated for the number of pathological lesions detected. Measured uptake for lesions was evaluated by maximum and mean standardized uptake value (SUVmax and SUVmean, respectively) and tumour-to-backround ratio (TBR) were compared. Agreement between the three acquisitions was compared by Krippendorfs alpha. RESULTS: Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (Ks α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p
- Published
- 2021